Rakovina Therapeutics appoints Professor Petra Hamerlik to its board
Professor Petra Hamerlik, Chair of Translational Neuro-Oncology at the University of Manchester and previously a member of the company’s Scientific Advisory Board, was elected at Rakovina Therapeutics’ 2026 Annual General Meeting.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.